Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. VOLTAFLEX
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
  • Date 20 November 2013
  • Documents : 3
  • History
Download opinion
Listen Listen
Add to my selection
  • Clinical Benefit
Quote this publication
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

VOLTAFLEX

-
Opinions on drugs - Posted on Apr 01 2014

Reason for request

Re-assessment of the actual benefit pursuant to the findings of the

-


Clinical Benefit

Insufficient

Insufficient Actual Benefit


Documents

  • VOLTAFLEX_20112013_AVIS_CT13097 Xvox
  • DOLENIO_FLEXEA_OSAFLEXAN_STRUCTOFLEX_VOLTAFLEX_20112013_SYNTHESE Xvox

English version

  • VOLTAFLEX_CT13097_Version anglaise Xvox
All our publications
    Drug therapy Joint and rheumatic diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
ZfhCCgNJFV4TPUsZ